Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting (111)In-Trastuzumab for Potential Combination Therapies

(111)In-labeled trastuzumab modified with nuclear localizing signal (NLS) peptides ((111)In-trastuzumab-NLS) efficiently delivers an Auger electron (AE) emitter (111)In into the cell nucleus and is thus a promising radiopharmaceutical in AE radioimmunotherapy (AE-RIT) for targeted killing of HER2-po...

詳細記述

保存先:
書誌詳細
出版年:Cancer Biother Radiopharm
主要な著者: Li, Huizi Keiko, Morokoshi, Yukie, Daino, Kazuhiro, Furukawa, Takako, Kamada, Tadashi, Saga, Tsuneo, Hasegawa, Sumitaka
フォーマット: Artigo
言語:Inglês
出版事項: Mary Ann Liebert, Inc. 2015
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4601633/
https://ncbi.nlm.nih.gov/pubmed/26447839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2015.1882
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料